Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|August 18, 2015
Analytical and statistical comparability of generic enoxaparins from the US market with the originator productPierre A J Mourier, Christophe Agut, Hajer Souaifi-Amara, et al.
The Journal of Biological Chemistry|July 22, 2008
Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residueMarco Guerrini, Sara Guglieri, Benito Casu, et al.
Seminars in Thrombosis and Hemostasis|July 17, 2007
High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanaseAntonella Bisio, Alessandra Mantegazza, Elena Urso, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 20, 2014
Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System ModelErnesto Luna, Pankaj Agrawal, Riyaz Mehta, et al.
The Biochemical Journal|October 23, 2012
An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequenceMarco Guerrini, Stefano Elli, Pierre Mourier, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 21, 2009
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparinChristian Viskov, E Bouley, P Hubert, et al.
The Journal of Biological Chemistry|July 12, 2013
Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological propertiesChristian Viskov, Stefano Elli, Elena Urso, et al.
Journal of Medicinal Chemistry|October 30, 2010
Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparinMarco Guerrini, Stefano Elli, Davide Gaudesi, et al.
Thrombosis Research|April 5, 2011
A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparinWalter P Jeske, Debra Hoppensteadt, Angel Gray, et al.
Thrombosis Research|May 8, 2007
Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosisJoana C Santos, Juliana M F Mesquita, Celso L R Belmiro, et al.
Pageof 3